These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1684507)

  • 1. The role of CD4 and CD8 T cells in viral infections.
    Koszinowski UH; Reddehase MJ; Jonjic S
    Curr Opin Immunol; 1991 Aug; 3(4):471-5. PubMed ID: 1684507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.
    Pouniotis DS; Esparon S; Apostolopoulos V; Pietersz GA
    Immunol Cell Biol; 2011 Nov; 89(8):904-13. PubMed ID: 21383765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.
    Ossendorp F; Mengedé E; Camps M; Filius R; Melief CJ
    J Exp Med; 1998 Mar; 187(5):693-702. PubMed ID: 9480979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of CTL and nonpolarized Th cell responses by CD8alpha(+) and CD8alpha(-) dendritic cells.
    Schlecht G; Leclerc C; Dadaglio G
    J Immunol; 2001 Oct; 167(8):4215-21. PubMed ID: 11591742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 is needed for development of cytotoxic T cells but not helper T cells.
    Fung-Leung WP; Schilham MW; Rahemtulla A; Kündig TM; Vollenweider M; Potter J; van Ewijk W; Mak TW
    Cell; 1991 May; 65(3):443-9. PubMed ID: 1673361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fewer protective cytotoxic T-cell epitopes than T-helper-cell epitopes on vesicular stomatitis virus.
    Kündig TM; Castelmur I; Bachmann MF; Abraham D; Binder D; Hengartner H; Zinkernagel RM
    J Virol; 1993 Jun; 67(6):3680-3. PubMed ID: 7684471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo.
    Lee RS; Grusby MJ; Glimcher LH; Winn HJ; Auchincloss H
    J Exp Med; 1994 Mar; 179(3):865-72. PubMed ID: 8113680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection.
    Denkers EY; Scharton-Kersten T; Barbieri S; Caspar P; Sher A
    J Exp Med; 1996 Jul; 184(1):131-9. PubMed ID: 8691126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal skin-derived MHC class I+, MHC class II- dendritic cells stimulate MHC class I-restricted responses of unprimed CD8+ T cells.
    Elbe A; Schleischitz S; Strunk D; Stingl G
    J Immunol; 1994 Oct; 153(7):2878-89. PubMed ID: 7522244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
    Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
    Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditioned dendritic cells as a temporal bridge between T helper and cytotoxic cells.
    Hall BM; Chen J; Robinson C; He XY; Plain K; Verma N; Hodgkinson ST
    Transplant Proc; 2001; 33(1-2):195-6. PubMed ID: 11266776
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.
    Rosenberg AS; Munitz TI; Maniero TG; Singer A
    J Exp Med; 1991 Jun; 173(6):1463-71. PubMed ID: 1674524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
    Asnagli H; Schmitt-Verhulst AM; Guimezanes A
    J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of T cell help for anti-viral CTL responses.
    Wodarz D; Jansen VA
    J Theor Biol; 2001 Aug; 211(4):419-32. PubMed ID: 11476625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1.
    Altfeld M; Rosenberg ES
    Curr Opin Immunol; 2000 Aug; 12(4):375-80. PubMed ID: 10899028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
    Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
    J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
    McMenamin C; Holt PG
    J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.